Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial-Reference-Cited by-同舟云学术

Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial

Published:2021-02 Issue:2 Volume:40 Page:71-76
ISSN:2174-2049
Container-title:Revista Portuguesa de Cardiologia (English Edition)
language:en
Short-container-title:Revista Portuguesa de Cardiologia (English Edition)

Author:

Prado Jr Guy F.A.,Abizaid Alexandre A.C.,Meireles George C.,Sarmento-Leite Rogério,Prudente Mauricio,Cantarelli Marcelo,Dourado Adriano D.,Jr Jose Mariani,Perin Marco A.,Costantini Costantino,Costa Ricardo,Costa J. Ribamar,Chamie Daniel,Campos Carlos M.,Ribeiro Expedito E.,Lemos Pedro A.

Publisher

Elsevier BV

Reference14 articles.

1. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis;Palmerini;J Am Coll Cardiol,2015

2. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study;Nakazawa;Circulation,2008

3. Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

4. Randomized comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention: the SORT OUT VII Trial;Jensen;Circ Cardiovasc Interv,2016

5. Mid- and long-term outcome comparisons of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents: a systematic review and meta-analysis;Zhang;Ann Intern Med,2017